Associated Papers
PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer.
Ren X et al.
Journal of Cancer Research and Clinical Oncology, 2024
38466449 (PubMed )
Supplement: 432_2024_5626_MOESM11_ESM.xls › Sheet1
Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis.
Ye ZL et al.
Cancer Medicine, 2020
A microscopic landscape of the invasive breast cancer genome.
Ping Z et al.
Scientific Reports, 2016
27283966 (PubMed )
Supplement: srep27545-s1.xls › suppl_table_1_IDC_histologic_gr
Identification of somatic gene mutations in penile squamous cell carcinoma.
Ferrándiz-Pulido C et al.
Genes, Chromosomes & Cancer, 2015
Evidence for different expression profiles for c-Met, EGFR, PTEN and the mTOR pathway in low and high grade endometrial carcinomas in a cohort of consecutive women. Occurrence of PIK3CA and K-Ras mutations and microsatellite instability.
Thoury A et al.
Histology and Histopathology, 2014
Comprehensive molecular portraits of human breast tumours.
Unknown Author
Nature, 2012
23000897 (PubMed )
Supplement: NIHMS393293-supplement-2.xls › SuppTable1
A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes.
Fumagalli D et al.
Bmc Cancer, 2010
Select a paper to view details